Efficacy of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma and Mutated or Deleted TP53
Klara Acs, Juho J. Miettinen, Philipp Sergeev, Tobias Heckel, Yumei Diao, Kristina Witt-Mulder, Marcus Thureson, Thorsten Bischler, Maiju-Emilia Huppunen, Jakob Obermüller, Umair Munawar, Ana Slipicevic, Ralf C. Bargou, Fredrik Lehmann, Stefan Svensson Gelius, Stefan Norin, Fredrik Schjesvold, Pieter Sonneveld, Thorsten Stühmer, Caroline A. Heckman
doi: https://doi.org/10.1101/2024.12.02.24318289
